Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0PC5A
|
||||
Former ID |
DNC009879
|
||||
Drug Name |
VER-156084
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Neuropathic pain [ICD9: 356.0, 356.8; ICD10:G64, G90.0] | Investigative | [530200] | ||
Structure |
Download2D MOL |
||||
Formula |
C21H23Cl2N3O2
|
||||
Canonical SMILES |
C1CCN(CC1)C(=O)N2CC(C2)OC(C3=CC=C(C=C3)Cl)C4=C(N=CC=C4)<br />Cl
|
||||
InChI |
1S/C21H23Cl2N3O2/c22-16-8-6-15(7-9-16)19(18-5-4-10-24-20(18)23)28-17-13-26(14-17)21(27)25-11-2-1-3-12-25/h4-10,17,19H,1-3,11-14H2/t19-/m0/s1
|
||||
InChIKey |
QEKKZTBXSULKCC-IBGZPJMESA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cannabinoid receptor 2 | Target Info | Inhibitor | [530200] | |
Cannabinoid receptor 1 | Target Info | Inhibitor | [530200] | ||
Fatty-acid amide hydrolase | Target Info | Inhibitor | [530200] | ||
BioCyc Pathway | Anandamide degradation | ||||
PANTHER Pathway | Endogenous cannabinoid signalingP05728:Anandamide degradation | ||||
Pathway Interaction Database | N-cadherin signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.